Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics

A Kulkarni, K Preeti, KP Tryphena, S Srivastava… - Ageing Research …, 2023 - Elsevier
The protein dyshomeostasis is identified as the hallmark of many age-related
neurodegenerative disorders including Parkinson's disease (PD). The diseased brain shows …

[HTML][HTML] Dynamic regulation of DNA methylation and brain functions

J Xie, L Xie, H Wei, XJ Li, L Lin - Biology, 2023 - mdpi.com
Simple Summary DNA methylation is involved in biological processes including
neurogenesis, aging, and the pathogenesis of brain disorders by the regulation of gene …

[HTML][HTML] Environmental impact on the epigenetic mechanisms underlying Parkinson's disease pathogenesis: a narrative review

E Angelopoulou, YN Paudel, SG Papageorgiou… - Brain Sciences, 2022 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder with an
unclear etiology and no disease-modifying treatment to date. PD is considered a …

[HTML][HTML] Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders

O Martínez-Iglesias, V Naidoo, I Carrera, L Corzo… - Pharmaceuticals, 2023 - mdpi.com
Neurodegenerative disorders (NDDs) are major health issues in Western countries. Despite
significant efforts, no effective therapeutics for NDDs exist. Several drugs that target …

[HTML][HTML] Influence of metabolic, transporter, and pathogenic genes on pharmacogenetics and DNA methylation in neurological disorders

O Martínez-Iglesias, V Naidoo, I Carrera, JC Carril… - Biology, 2023 - mdpi.com
Simple Summary The prevalence of neurodegenerative disorders has increased, yet
reliable, pre-symptomatic biomarkers for early detection and subsequent preventive …

Characterization of hemodynamic alteration in Parkinson's disease and effect on resting-state Connectivity

D Zhang, Q Fu, C Xue, C Xiao, Y Sun, W Liu, X Hu - Neuroscience, 2023 - Elsevier
Functional magnetic resonance imaging (fMRI) is a convolution of latent neural activity and
the hemodynamic response function (HRF). According to prior studies, the …

[HTML][HTML] Neuroprotective Effects of Zinc Oxide Nanoparticles in a Rotenone-Induced Mouse Model of Parkinson's Disease

Y Khafajah, M Shaheen, D El Natour, M Merheb… - …, 2024 - ncbi.nlm.nih.gov
Goals of the investigation: This work aimed to evaluate the neuroprotective effects of zinc
oxide (ZnO) nanoparticles in an experimental mouse model of rotenone-induced PD and …

[HTML][HTML] AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines

O Martínez-Iglesias, I Carrera, V Naidoo, R Cacabelos - Life, 2022 - mdpi.com
Novel and effective chemotherapeutic agents are needed to improve cancer treatment.
Epidrugs are currently used for cancer therapy but also exhibit toxicity. Targeting the …

Genome-Wide Association Study of Histopathological Quantification Methods in Primary Age-Related Tauopathy

BM Babrowicz - 2024 - search.proquest.com
Alzheimer's disease (AD) is characterized by beta-amyloid (Aß) plaques and
hyperphosphorylated tau containing neurofibrillary tangles (NFTs) throughout the brain. In …

[PDF][PDF] Tratamiento epigenético en personas con enfermedad de Parkinson (EP)

A Covaleda Navarro - 2023 - academica-e.unavarra.es
Resumen Contextualización: La Enfermedad de Parkinson (EP) es la segunda enfermedad
neurodegenerativa más común en la actualidad y la que mayor crecimiento tiene a nivel …